When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Your ED Pill Guide: Everything You Need to Know Before ... - AOL

   www.aol.com/ed-pill-guide-everything-know...

   A study published in PLOS One in 2015 analyzed the relationship between coffee drinking and ED by looking at 3,724 men aged 20 and above. These guys were surveyed about their eating and drinking ...

3. Simvastatin - Wikipedia

   en.wikipedia.org/wiki/Simvastatin

   Simvastatin is an effective serum lipid-lowering drug that can decrease low density lipoprotein (LDL) levels by up to 50%. [citation needed] Simvastatin had been shown to interact with lipid-lowering transcription factor PPAR-alpha [36] and that interaction might control the neurotrophic action of the drug.

4. 4 Common ED Pills: Weighing the Pros & Cons of Each - AOL

   www.aol.com/4-common-ed-pills-weighing-141800609...

   The Best ED Medication for Men: Pros & Cons of Top ED Pills. Over the last 25 years, (ED) medications like Viagra and Cialis have become common fixtures in bedrooms around the world.

5. There's a New Over-the-Counter ED Drug. Should You Be ... - AOL

   www.aol.com/lifestyle/theres-over-counter-ed...

   Dr. Pearlman says the availability of an easy-to-access treatment for men dealing with ED is welcome news. ... The $3.99 Trader Joe’s freezer find I buy when I can’t be bothered to cook.

6. Erectile dysfunction - Wikipedia

   en.wikipedia.org/wiki/Erectile_dysfunction

   The term erectile dysfunction does not encompass other erection-related disorders, such as priapism. Treatment of ED encompasses addressing the underlying causes, lifestyle modification, and addressing psychosocial issues. [4] In many instances, medication-based therapies are used, specifically PDE5 inhibitors such as sildenafil. [13]

7. Ezetimibe/simvastatin - Wikipedia

   en.wikipedia.org/wiki/Ezetimibe/simvastatin

   With median follow-up of 6 years, simvastatin+ezetimibe was found to reduce the primary outcome of CV mortality, major CV event, or nonfatal stroke (34.7% vs. 32.7%; P=0.016; NNT 50 per 7 years or NNT 350 per 1 year ). There was no reduction in all-cause or CV mortality with simvastatin+ezetimibe, though there was a reduction in MI and stroke. [6]